CAN WE SAFELY USE OVARIAN HYPERSTIMULATION IN INFERTILE PATIENTS AFTER FSS FOR EPITHELIAL TUMORS?

ESGO eAcademy, Dominik Denschlag, 202702

CERVICAL CANCER

ESGO eAcademy, Daniela Fischerova, 202707

FERTILITY SPARING MANAGEMENT IN HIGH RISK EPITHELIAL OVARIAN CANCER

ESGO eAcademy, Enrica Bentivegna, 202701

Imaging in the diagnosis and management of endometrial cancer

ESGO eAcademy, Ingfrid Haldorsen, 202706

CHANGES IN NEOANGIOGENETIC PROFILE OF PAIRED PRIMARY AND RECURRENT HIGH-GRADE SEROUS OVARIAN CANCER (HGOSC): A STUDY OF THE “OCTIPS” CONSORTIUM.

ESGO eAcademy, Ilary Ruscito, 202699

CISPLATIN CHEMO-RADIATION VERSUS RADIATION IN FIGO STAGE IIIB SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX (CRACX TRIAL: NCT00193791)

ESGO eAcademy, Umesh Mahantshetty, 202698

AGO-OVAR 12: A RANDOMIZED PLACEBO-CONTROLLED GCIG/ENGOT-INTERGROUP PHASE III TRIAL WITH CHEMOTHERAPY +/- NINTEDANIB FOR ADVANCED OVARIAN CANCER: OVERALL SURVIVAL RESULTS

ESGO eAcademy, Isabelle Ray-Coquard, 202697

EMBRACE THE MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCER

ESGO eAcademy, Tjalling Bosse, 202696

Randomized Controlled Phase III Study To Evaluate Secondary Cytoreductive Surgery In Platinum-Sensitive Recurrent Ovarian Cancer - AGO Desktop III/ENGOT Ov20

ESGO eAcademy, Jalid Sehouli, 202904

Medical treatment of uterine carcinosarcoma

ESGO eAcademy, Isabelle Ray-Coquard, 190586

Surgical treatment of serous endometrial cancer

ESGO eAcademy, Frederic Guyon, 190585

Long- term therapy with gonadoliberin analogues in patient with ovarian cancer.

ESGO eAcademy, Session Speakers, 191006

High grade serous ovarian cancer stage IV, multiple relapses

ESGO eAcademy, Session Speakers, 191003

Ovarian Cancer in Pregnancy

ESGO eAcademy, Session Speakers, 190595

Surgical treatment of low grade serous ovarian cancer

ESGO eAcademy, Jalid Sehouli, 180471

Medical Tumor Therapy for Germ Cell Tumors of Adults

ESGO eAcademy, Michael Seckl, 180466

Systemic treatment for low grade serous carcinoma

ESGO eAcademy, Michael Seckl, 180469

Surgical treatment for malignant germ cell tumor.

ESGO eAcademy, Pauline Wimberger, 180467

Pathologic aspects of Germ Cell Tumors

ESGO eAcademy, Doris Mayr, 180468

Pathologic aspects of Low Grade Serous Ovarian Cancer

ESGO eAcademy, Doris Mayr, 180470

Look into the future: Medical treatment of ovarian cancer in 2026

ESGO eAcademy, Ignace Vergote, 173572

Immunotherapy in gynecological malignancies

ESGO eAcademy, An Coosemans, 173570

Why do studies of targeted treatment fail?

ESGO eAcademy, Jonathan Ledermann, 173568

Targeting PARP: Mechanisms of action, available evidence, selection of patients, management of toxicities

ESGO eAcademy, Jonathan Ledermann, 173567

Targeting tyrosine kinases

ESGO eAcademy, Jonathan Ledermann, 173566

Molecular pathways in cervical cancer

ESGO eAcademy, Heidi Lyng, 173565

Molecular pathways in endometrial cancer

ESGO eAcademy, Henrica Maria Johanna Werner, 173564

Molecular pathways of low-grade ovarian cancer

ESGO eAcademy, Kristina Lindemann, 173563

Molecular pathways of high grade ovarian cancer

ESGO eAcademy, Adriaan Vanderstichele, 173562

Surgical aspects of uterine carcinosarcoma (~ serous)

ESGO eAcademy, Frederic Amant, 173558

Ultrasound guided procedures

ESGO eAcademy, Michal Zikan, 173920

Ovarian cancer staging

ESGO eAcademy, Daniela Fischerova, 173919

Endometrial cancer diagnosis and staging

ESGO eAcademy, Elisabeth Epstein, 173918

Cervical cancer staging

ESGO eAcademy, Antonia Testa, 173917

Abdominal scan

ESGO eAcademy, Daniela Fischerova, 173916

Pelvic imaging

ESGO eAcademy, Daniela Fischerova, 173915

Introduction

ESGO eAcademy, David Cibula, 173914

Uterine carcinosarcoma: radiotherapy

ESGO eAcademy, Carien Creutzberg, 173556

Serous endometrial cancer: radiotherapy

ESGO eAcademy, Carien Creutzberg, 173557

Serous endometrial cancer: current management and targeted therapies

ESGO eAcademy, Annamaria Ferrero, 173555

PMMR in endometrial cancer - Part one - Compartmental lymphatic network of uterine corpus and its drainage

ESGO eAcademy, K. Rainer Kimmig, 166631

PMMR in endometrial cancer - Part two - Surgical technique

ESGO eAcademy, K. Rainer Kimmig, 166632

Adjuvant Treatment and Place of Radiation Therapy in Vulvar Cancer

ESGO eAcademy, Carien Creutzberg, 150846

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

ESGO eAcademy, Mansoor Raza Mirza, 154789

New ESGO Guidelines of Management of Vulvar Cancer

ESGO eAcademy, Ate van der Zee, 150845

How to Stage Locally Advanced Cervical Cancer (Radiological and Surgical) before Chemoradiation Therapy

ESGO eAcademy, Sebastien Gouy, 150844

Management of the Clear Cell Ovarian Carcinoma

ESGO eAcademy, Keiichi Fujiwara, 150843

Phase 2: What Information Can We Derive? Rational, Design and Objectives

ESGO eAcademy, Jonathan Ledermann, 150268

Surrogate Endpoints

ESGO eAcademy, Paolo Bruzzi, 150266

Phase 1/1B: What Information Can We Derive? Rational, Design and Objectives

ESGO eAcademy, Cristina Sessa, 150267

Statistical Plans, Interim Analysis and Subgroup Analysis

ESGO eAcademy, Paolo Bruzzi, 150265

Vulvar Cancer: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Fabio Landoni, 150264

Endometrial Cancer: What Do We Know? What Don't We Know ? What Should Be Investigated?

ESGO eAcademy, Eric Pujade-Lauraine, 150263

Uterine Sarcoma: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Andres Poveda, 150262

Cervical Cancer: What Do We Know? What Don't We Know? What Should Be Investigated?

ESGO eAcademy, Christian Marth, 150261

Welcome & Introduction

ESGO eAcademy, Nicoletta Colombo, 150269

New Classification of Uterine Sarcoma

ESGO eAcademy, Sabrina Croce, 147380

Gastric-type Mucinous Cervical Adenocarcinoma

ESGO eAcademy, Mojgan Devouassoux, 148332

Vulvovaginal Glandular Neoplasia

ESGO eAcademy, Mojgan Devouassoux, 148333

Pathology of Clear Cell Ovarian Tumors

ESGO eAcademy, Ester Oliva, 147379

New Classification and Molecular of Endometrial Cancers

ESGO eAcademy, Sigurd Lax, 147381

Pathologic Characteristics of Mucinous Tumors (Borderline and Invasive: Infltrative/expansile Subtypes)

ESGO eAcademy, Sigurd Lax, 147383

Aortic Extraperitoneal Lymphadenectomy

ESGO eAcademy, Lucas Minig, 148602

Peritoneal Suture During Extraperitoneal Lymphadenectomy

ESGO eAcademy, Lucas Minig, 148603

Sentinel Node Detection

ESGO eAcademy, Lucas Minig, 148604

Dissection of the Avascular Spaces of the Pelvis

ESGO eAcademy, Lucas Minig, 148605

Pelvic Lymphadenectomy

ESGO eAcademy, Lucas Minig, 148606

Radical Oophorectomy with Colorectal Resection for Advanced Ovarian Cancer

ESGO eAcademy, Lucas Minig, 148607

Ileo-Colic Resection with Anastomosis for Advanced Ovarian Cancer

ESGO eAcademy, Lucas Minig, 148608

Pathological and Molecular Classification of Epithelial Ovarian Cancer

ESGO eAcademy, Sigurd Lax, 147382

Restoring the Function of Mutated P53 - a Major Contribution to Carcinogenesis

ESGO eAcademy, John A Green, 147116

Genetic Testing in Ovarian Cancer Patients: How Far Should We Go

ESGO eAcademy, Charlie Gourley, 147115

Adjuvant Therapeutic Approaches by Histological Subtype with Implications for Treatment

ESGO eAcademy, Jonathan Ledermann, 147114

Prophylactic Surgery in High Risk Population

ESGO eAcademy, Christina Fotopoulou, 147112

Laser Skinning Vulvectomy

ESGO eAcademy, Michael G. Halaska, 147110

LEEP/LLETZ and Needle Conization

ESGO eAcademy, Ilker Selcuk, 147109

Cold Knife Conization and Sturmdorf Technique

ESGO eAcademy, Ignacio Zapardiel, 147108

Simple Solutions for Developing Countries for Breast Cancer Screening

ESGO eAcademy, Murat Gultekin, 147106

Current Situation of Breast Cancer Screening Startegies in Europe and Around the World

ESGO eAcademy, Larry von Karsa, 147105

Evaluation of Mammography for the Detection of Breast Cancer in Screening Programs

ESGO eAcademy, Peter Dean, 147104

Molecular Cancer Genetics

ESGO eAcademy, Henrica Maria Johanna Werner, 147103

Endometrial Cancers Prevention and Screening Methods

ESGO eAcademy, Thierry A.M. Van Den Bosch, 147102

Chemoprevention of Endometrial Cancers

ESGO eAcademy, Pauline Wimberger, 147100

Obesity and Gynaecological Cancers

ESGO eAcademy, Maria Kyrgiou, 147099

Follow-up and Treatment of Recurrences

ESGO eAcademy, Vesna Kesic, 147098

Should CIN2 Lesions Be Treated and When?

ESGO eAcademy, Maria Kyrgiou, 147097

Screening after Vaccination

ESGO eAcademy, Jack Cuzick, 147096

Novel Molecular Techniques in Screening & Diagnosis & Prediction

ESGO eAcademy, Jack Cuzick, 147094

Cytology vs. HPV for Primary Screening

ESGO eAcademy, Marc Arbyn, 147093

Cervical Cancer Screening in Low and High Resource Settings

ESGO eAcademy, Partha Basu, 147092

HPV Prophylactic Vaccines: Lessons Learned from 10 Years Experiences

ESGO eAcademy, Xavier Bosch, 147090

HPV Related Cancers: the Comparative Figures in the World

ESGO eAcademy, Partha Basu, 147089

The Human Papillomavirus Types and the Type-specific Risks for Disease

ESGO eAcademy, Joakim Dillner, 147088

Quality Assurance for the Surgical Management of Ovarian Cancer and ESGO Certification

ESGO eAcademy, Denis Querleu, 139309

Goals and Limits of Surgery in Advanced Ovarian Cancer

ESGO eAcademy, Luis M. Chiva, 139308

Combining a Surgical and Treatment Question in the Same Trial. Is It Feasible?

ESGO eAcademy, Mansoor Raza Mirza, 135850

Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: a Unique Opportunity for Traslational Research

ESGO eAcademy, Sandro Pignata, 135849

Algorithm To Select Patients for Primary Cytoreductive Surgery versus Neoadjuvant Chemotherapy

ESGO eAcademy, Christian Marth, 135848

Quality Assessment in Ovarian Cancer Surgery

ESGO eAcademy, Andreas Du Bois, 135847

Immune Check Points

ESGO eAcademy, Iain McNeish, 135846